{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:40:14Z","timestamp":1773304814603,"version":"3.50.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10,21]]},"abstract":"<jats:p>This study aimed to examine the prevalence and time interval of metabolic syndrome (MS) development among women with hypertensive disorders of pregnancy (HDP) compared to women with a normal delivery. Data (4,723,541 deliveries) from 2002 to 2012 from the National Health Insurance System Database in Korea were used to compare women diagnosed with HDP with those with a normal singleton pregnancy. Using the customized database, we conducted a longitudinal analysis of MS development. MS was observed in 20.3% of the patients in the normal delivery group and 37.1% in the HDP group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.0001). The time to MS development in the HDP group was significantly shorter than that in the normal delivery group (6.6\u2005\u00b1\u20053.4 vs 8.2\u2005\u00b1\u20053.4 years, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.0001). The HDP group had a significantly increased risk [odd ratio (OR) 1.23; 95% confidence interval (CI), 1.12\u20131.35] of developing MS, and elevated systolic blood pressure strongly contributed to the increased risk of developing MS (OR 1.644; 95% CI, 1.610\u20131.678). HDP increased the risk of MS development later in life, and MS development exhibited a shorter time period in women with HDP. Women with HDP should undergo intensive assessment for MS components.<\/jats:p>","DOI":"10.1097\/md.0000000000031272","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T19:14:49Z","timestamp":1666638889000},"page":"e31272","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["The presence of hypertension during pregnancy determines the future risk of metabolic syndrome: An observational study"],"prefix":"10.1097","volume":"101","author":[{"given":"Da-Hye","family":"Ju","sequence":"first","affiliation":[{"name":"Division of Obstetrics, Department of OBGY, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeyoun","family":"Lee","sequence":"additional","affiliation":[{"name":"DataEngineersLab, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4275-6538","authenticated-orcid":false,"given":"Sang Jin","family":"Ha","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Republic of Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0140-6736(06)68397-9","article-title":"WHO analysis of causes of maternal death: a systematic review.","volume":"367","author":"Khan","year":"2006","journal-title":"Lancet"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/bmj.39335.385301.BE","article-title":"Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis.","volume":"335","author":"Bellamy","year":"2007","journal-title":"BMJ"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1479-828X.2009.01003.x","article-title":"Guidelines for the management of hypertensive disorders of pregnancy 2008.","volume":"49","author":"Lowe","year":"2009","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/bmj.325.7356.157","article-title":"Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?","volume":"325","author":"Sattar","year":"2002","journal-title":"BMJ"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/jhh.2012.45","article-title":"Does a history of hypertensive disorders of pregnancy help predict future essential hypertension? Findings from a prospective pregnancy cohort study.","volume":"27","author":"Callaway","year":"2013","journal-title":"J Hum Hypertens"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/bmj.326.7394.845","article-title":"Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study.","volume":"326","author":"Wilson","year":"2003","journal-title":"BMJ"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"e1001425","DOI":"10.1371\/journal.pmed.1001425","article-title":"Preeclampsia as a risk factor for diabetes: a population-based cohort study.","volume":"10","author":"Feig","year":"2013","journal-title":"PLoS Med"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/S0140-6736(00)05112-6","article-title":"Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births.","volume":"357","author":"Smith","year":"2001","journal-title":"Lancet"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/01.CIR.0000108926.04022.0C","article-title":"Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey.","volume":"109","author":"Ninomiya","year":"2004","journal-title":"Circulation"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2337\/diacare.28.7.1769","article-title":"Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence.","volume":"28","author":"Ford","year":"2005","journal-title":"Diabetes Care"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/01.AOG.0000163252.02227.f8","article-title":"Early occurrence of metabolic syndrome after hypertension in pregnancy.","volume":"105","author":"Forest","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1161\/01.HYP.0000120122.39231.88","article-title":"Manifestations of metabolic syndrome after hypertensive pregnancy.","volume":"43","author":"Pouta","year":"2004","journal-title":"Hypertension"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2188\/jea.JE20140136","article-title":"Subsequent risk of metabolic syndrome in women with a history of preeclampsia: data from the Health Examinees Study.","volume":"25","author":"Yang","year":"2015","journal-title":"J Epidemiol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1111\/1471-0528.13117","article-title":"Metabolic syndrome after pregnancies complicated by pre-eclampsia or small-for-gestational-age: a retrospective cohort.","volume":"122","author":"Al-Nasiry","year":"2015","journal-title":"BJOG"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jogn.2016.02.004","article-title":"Pregnancy reveals evolving risk for cardiometabolic disease in women.","volume":"45","author":"Ferranti","year":"2016","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4093\/dmj.2016.40.1.79","article-title":"Data analytic process of a nationwide population-based study using national health information database established by National Health Insurance Service.","volume":"40","author":"Lee","year":"2016","journal-title":"Diabetes Metab J"},{"key":"R18-20250504","first-page":"e15","article-title":"Cohort Profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea.","volume":"46","author":"Lee","year":"2017","journal-title":"Int J Epidemiol"},{"key":"R19-20250504","first-page":"1122","article-title":"Report of the American College of obstetricians and gynecologists\u2019 task force on hypertension in pregnancy.","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement.","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11892-006-0054-3","article-title":"Metabolic syndrome in the elderly.","volume":"6","author":"Bechtold","year":"2006","journal-title":"Curr Diab Rep"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.amjmed.2006.02.031","article-title":"Metabolic syndrome and risk of cardiovascular disease: a meta-analysis.","volume":"119","author":"Galassi","year":"2006","journal-title":"Am J Med"},{"key":"R23-20250504","first-page":"775","article-title":"A follow-up study of women with a history of severe preeclampsia: relationship between metabolic syndrome and preeclampsia.","volume":"124","author":"Lu","year":"2011","journal-title":"Chin Med J (Engl)"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/AOG.0b013e3181bb0dfc","article-title":"Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors.","volume":"114","author":"Magnussen","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/CIRCULATIONAHA.110.943407","article-title":"Hypertension in pregnancy and later cardiovascular risk: common antecedents?","volume":"122","author":"Romundstad","year":"2010","journal-title":"Circulation"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S1701-2163(16)35382-8","article-title":"Risk estimation of metabolic syndrome at one and three years after a pregnancy complicated by preeclampsia.","volume":"34","author":"Smith","year":"2012","journal-title":"J Obstet Gynaecol Can"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/OGX.0b013e31827682fc","article-title":"Biochemical cardiovascular risk factors after hypertensive pregnancy disorders: a systematic review and meta-analysis.","volume":"67","author":"Hermes","year":"2012","journal-title":"Obstet Gynecol Surv"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.atherosclerosis.2004.01.038","article-title":"Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy?","volume":"175","author":"Rodie","year":"2004","journal-title":"Atherosclerosis"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1161\/HYPERTENSIONAHA.107.101873","article-title":"Shared constitutional risks for maternal vascular-related pregnancy complications and future cardiovascular disease.","volume":"51","author":"Berends","year":"2008","journal-title":"Hypertension"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1586\/14779072.5.2.283","article-title":"Preeclampsia and future cardiovascular risk.","volume":"5","author":"Newstead","year":"2007","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"R31-20250504","first-page":"1029","article-title":"Microvascular dysfunction: a link between pre-eclampsia and maternal coronary heart disease.","volume":"110","author":"Ramsay","year":"2003","journal-title":"BJOG"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/clc.21965","article-title":"Preeclampsia and hypertensive disease in pregnancy: their contributions to cardiovascular risk.","volume":"35","author":"Valdiviezo","year":"2012","journal-title":"Clin Cardiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031272","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:41:42Z","timestamp":1746333702000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":32,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000031272","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,21]]}}}